• Je něco špatně v tomto záznamu ?

Changes in cardiovascular autonomic control induced by chronic inhibition of acetylcholinesterase during pyridostigmine or donepezil treatment of spontaneously hypertensive rats

M. Bencze, A. Boroš, M. Behuliak, A. Vavřínová, I. Vaněčková, J. Zicha

. 2024 ; 971 (-) : 176526. [pub] 20240325

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24013926

Chronic treatment with acetylcholinesterase inhibitors may be a promising therapeutic strategy for treatment of cardiovascular diseases. The aim of our study was to analyze the changes in blood pressure (BP) and heart rate (HR) during 14 days of treatment with two different acetylcholinesterase inhibitors - pyridostigmine (PYR) having only peripheral effects or donepezil (DON) with both peripheral and central effects. In addition, we studied their effects on the cardiovascular response to restraint stress and on sympathovagal control of HR in normotensive Wistar-Kyoto rats (WKY) and spontaneously hypertensive rats (SHR). SHR were characterized by elevated BP and increased low-frequency component of systolic BP variability (LF-SBPV), but their cardiac vagal tone and HR variability (HRV) were reduced compared with WKY. Chronic treatment with either acetylcholinesterase inhibitor decreased HR and increased HRV in both strains. PYR treatment slightly decreased BP and LF-SBPV in the dark phase of the day. Neither drug significantly altered BP response to stress, but PYR attenuated HR increase during restraint stress. Regarding sympathovagal balance, acute methylatropine administration caused a greater increase of HR in WKY than in SHR. Chronic PYR or DON treatment enhanced HRV and HR response to methylatropine (vagal tone) in WKY, whereas PYR but not DON treatment potentiated HRV and vagal tone in SHR. In conclusion, vagal tone was lower in SHR compared with WKY, but was enhanced by chronic PYR treatment in both strains. Thus, chronic peripheral, but not central, acetylcholinesterase inhibition has major effects on HR and its variability in both normotensive and hypertensive rats.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24013926
003      
CZ-PrNML
005      
20240905133352.0
007      
ta
008      
240725e20240325ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.ejphar.2024.176526 $2 doi
035    __
$a (PubMed)38537804
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Bencze, Michal $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic
245    10
$a Changes in cardiovascular autonomic control induced by chronic inhibition of acetylcholinesterase during pyridostigmine or donepezil treatment of spontaneously hypertensive rats / $c M. Bencze, A. Boroš, M. Behuliak, A. Vavřínová, I. Vaněčková, J. Zicha
520    9_
$a Chronic treatment with acetylcholinesterase inhibitors may be a promising therapeutic strategy for treatment of cardiovascular diseases. The aim of our study was to analyze the changes in blood pressure (BP) and heart rate (HR) during 14 days of treatment with two different acetylcholinesterase inhibitors - pyridostigmine (PYR) having only peripheral effects or donepezil (DON) with both peripheral and central effects. In addition, we studied their effects on the cardiovascular response to restraint stress and on sympathovagal control of HR in normotensive Wistar-Kyoto rats (WKY) and spontaneously hypertensive rats (SHR). SHR were characterized by elevated BP and increased low-frequency component of systolic BP variability (LF-SBPV), but their cardiac vagal tone and HR variability (HRV) were reduced compared with WKY. Chronic treatment with either acetylcholinesterase inhibitor decreased HR and increased HRV in both strains. PYR treatment slightly decreased BP and LF-SBPV in the dark phase of the day. Neither drug significantly altered BP response to stress, but PYR attenuated HR increase during restraint stress. Regarding sympathovagal balance, acute methylatropine administration caused a greater increase of HR in WKY than in SHR. Chronic PYR or DON treatment enhanced HRV and HR response to methylatropine (vagal tone) in WKY, whereas PYR but not DON treatment potentiated HRV and vagal tone in SHR. In conclusion, vagal tone was lower in SHR compared with WKY, but was enhanced by chronic PYR treatment in both strains. Thus, chronic peripheral, but not central, acetylcholinesterase inhibition has major effects on HR and its variability in both normotensive and hypertensive rats.
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a zvířata $7 D000818
650    _2
$a potkani inbrední SHR $7 D011918
650    12
$a pyridostigmin-bromid $x farmakologie $7 D011729
650    _2
$a acetylcholinesterasa $7 D000110
650    _2
$a cholinesterasové inhibitory $x farmakologie $x terapeutické užití $7 D002800
650    _2
$a donepezil $x farmakologie $7 D000077265
650    _2
$a potkani inbrední WKY $7 D011921
650    12
$a hypertenze $x farmakoterapie $7 D006973
650    _2
$a krevní tlak $7 D001794
650    _2
$a srdeční frekvence $7 D006339
650    12
$a deriváty atropinu $7 D001286
655    _2
$a časopisecké články $7 D016428
700    1_
$a Boroš, Almos $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Behuliak, Michal $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Vavřínová, Anna $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Vaněčková, Ivana $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Zicha, Josef $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic. Electronic address: josef.zicha@fgu.cas.cz
773    0_
$w MED00001641 $t European journal of pharmacology $x 1879-0712 $g Roč. 971 (20240325), s. 176526
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38537804 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240725 $b ABA008
991    __
$a 20240905133346 $b ABA008
999    __
$a ok $b bmc $g 2143625 $s 1225792
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 971 $c - $d 176526 $e 20240325 $i 1879-0712 $m European journal of pharmacology $n Eur J Pharmacol $x MED00001641
LZP    __
$a Pubmed-20240725

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...